# Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR

> **NCT07227675** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 162 (actual)

## Conditions studied

- Mitral Regurgitation
- Mitral Valve Regurgitation

## Interventions

- **DEVICE:** MitraClip® NT System

## Key facts

- **NCT ID:** NCT07227675
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-23
- **Primary completion:** 2019-03-14
- **Final completion:** 2024-03-31
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2025-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07227675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07227675, "Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07227675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*